Linked Life Data

15057643

Source:http://linkedlifedata.com/resource/pubmed/id/15057643

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2004-4-1
pubmed:abstractText
DRAXIMAGE, under exclusive licence from BTG International Ltd, is developing a technetium-99m formulation of ciprofloxacin (INFECTON), as a radioimaging agent for the potential diagnosis of infection, including fever of unknown origin, osteomyelitis, wound infection, abdominal abscess, pneumonia, appendicitis and tuberculosis.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1369-7056
pubmed:author
pubmed:issnType
Print
pubmed:volume
7
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
374-9
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed:year
2004
pubmed:articleTitle
99mTc-ciprofloxacin DRAXIMAGE.
pubmed:affiliation
Essex Pharma GmbH, Tannenstrasse 15a, 42653 Solingen, Germany. gudrun.tossing@essex.de
pubmed:publicationType
Journal Article, Review